Genmab — Januar 2019
-
Jeg har ikke adgang til artiklen lige nu, men jeg kigger efter en gang til i morgen tidlig angående tidshorisonten.
-
Det der står er at FDA chefen siger at selvom en stor del af godkendelsesprocessen er betalt af selskaberne selv, så er der kun penge til 3 uger mere. Nedlukningen betyder ligeledes at d
er ikke kan modtages penge fra selskaber indtil der igen lukkes op. -
Den eneste mulige fortolkning ud fra det der står i Børsen må være at kommer der ikke en godkendelse indenfor 3 uger (og der fortsat ikke forefindes et godkendt budget), så bliver godkendelsen forsinket. I hvert fald hvis det falder ind under RTOR.
-
Og god morgen :-)(
-
Helt enig, og det er da bestemt ikke umuligt. Nedlukning eller ej, så regner man vel med at der ville være nyheder angående ansøgningsformen indenfor 3 uger alligevel?
-
Rajkumar mentioning Dara in PGNMID
https://twitter.com/VincentRK/status/1085400163106123776 which is this trial https://clinicaltrials.gov/ct2/show/NCT03095118 -
Scott Gottlieb on PDUFA - We’ll get into February but how far into Feb is still very fluid https://twitter.com/SGottliebFDA/status/1085317226150969344
-
Yes. Almost the same as in Børsen E L. So we can expect them to run out of money between 3-5 weeks including this week. That will hopefully leave enough time for the approval of 1.st line Darzalex or the budget.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
